The pharmaceutical giant Pfizer has settled a class-action lawsuit claiming the company did not adequately warn patients of the potential health risks posed by its dopamine drugs Cabaser and Dostinex. According to the FiercePharma article, Pfizer reached a multi-million dollar confidential settlement with 172 patients in an Australian court.
Plaintiffs in the class-action lawsuit claimed that Pfizer’s Cabaser and Dostinex caused them to develop previously nonexistent addictions to activities ...
continue reading...